Bintayan, Norie .
HRN: 22-70-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/14/2023
03/15/2023
IVT
4.5g
Q8 Hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes